Latest News about EYPT
Recent news which mentions EYPT
From Benzinga
From Benzinga
7 Wildly Oversold Nasdaq Stocks to Buy Now
July 12, 2022
From InvestorPlace
From Benzinga
From Benzinga
EyePoint Pharmaceuticals Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 28, 2022
Tickers
EYPT
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 03, 2022
From Benzinga
Earnings Scheduled For March 3, 2022
March 03, 2022
From Benzinga
The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom
December 08, 2021
From Benzinga
61 Biggest Movers From Yesterday
November 18, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Falls 200 Points; Rockwell Medical Shares Spike Higher
November 17, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 17, 2021
From Benzinga
Mid-Day Market Update: StoneCo Drops After Q3 Earnings; EyePoint Pharmaceuticals Shares Surge
November 17, 2021
From Benzinga
42 Stocks Moving In Wednesday's Mid-Day Session
November 17, 2021
From Benzinga
Mid-Morning Market Update: Markets Down; Lowe's Earnings Beat Estimates
November 17, 2021
From Benzinga
EyePoint Pharmaceuticals Raises $100M Via Capital Raise At 5% Discount
November 17, 2021
Tickers
EYPT
From Benzinga
The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment
November 17, 2021
From Benzinga
From InvestorPlace
41 Stocks Moving In Monday's Mid-Day Session
November 15, 2021
From Benzinga
TCNNF Stock: The Positive Pot News That Has Trulieve Cannabis Shares Lighting Up Today
November 15, 2021
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.